We are in the midst of a pandemic that could result in millions of premature deaths, billions in additional healthcare costs and trillions in lost economic growth, particularly in emerging markets that are increasingly being counted upon to drive global economic growth. Next September, the first-ever United Nations summit on non-communicable diseases will be held. It is a prime opportunity to elevate chronic disease -- like heart disease, diabetes, cancer and respiratory ailments -- on the global agenda. And it’s a life or death decision for the world’s human and economic health. One company -- Medtronic -- is bringing unique solutions to the unique challenges of chronic disease.